Protospiel South

Personal Information

I am a...

publisher

Your Website

https://pharmdevgroup.com/seven-noteworthy-505b2-submissions/

Personal Statement

As drug and device consultants, the scientists and regulatory experts at PDG® spend a considerable amount of time working on 505(b)(2) NDA submissions. This paper highlights notable features of a cross section of recent 505(b)(2) approvals and provides a variety of everyday issues to consider as you contemplate your next drug development project.

Call : 08133332950
Email : info@pharmdevgroup.com
Visit : https://pharmdevgroup.com/seven-noteworthy-505b2-submissions/

History

Member for

4 years 10 weeks